Royal Infirmary of Edinburgh
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RTX001 Autologous Engineered Macrophages for Liver Cirrhosis | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Jaundice, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, brain disorder, central nervous system disorder, chronic liver failure, cirrhosis of liver, hepatic encephalopathy, hyperbilirubinemia, liver disorder, liver failure, metabolic disease, nervous system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-05 | NCT06823713 | |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | bronchial disorder, bronchiectasis, respiratory system disorder | Recruiting | Phase 3 | 2026-10-01 | NCT06872892 | |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-09-30 | NCT06238622 | |
| Procedural Skills Transfer in Bronchoscopy | Respiration Disorders, respiratory system disorder | Recruiting | Not stated | 2026-09-21 | NCT07168408 | |
| A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies | Type 1 Interferonopathies | Active, not recruiting | Phase 1 | 2026-09-15 | NCT06878365 | |
| Neurovascular Product Surveillance Registry | Aneurysm, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2026-09-15 | NCT02988128 | |
| Non-invasive Coronary Thrombus Imaging to Define These Cause of Acute Myocardial Infarction | Embolism and Thrombosis, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, thrombotic disease, vascular disorder | Recruiting | Not stated | 2026-09-14 | NCT06113510 | |
| UK Infinity, Post-Market Clinical Follow-up Study | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2026-08-28 | NCT03063593 | |
| REDUCER-I: An Observational Study of the Neovasc Reducer™ System | Angina Pectoris, Angina, Stable, Chest Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not stated | 2026-07-30 | NCT02710435 | |
| Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial | Aneurysm, abdominal aortic aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, vascular disorder | Recruiting | Not applicable | 2026-07-06 | NCT05378347 | |
| A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-05-20 | NCT05595642 | |
| Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Recruiting | Phase 3 | 2026-05-13 | NCT05677971 | |
| Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes | Nutritional and Metabolic Diseases, autoimmune disease, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 2 | 2026-04-06 | NCT06435156 | |
| EMUs: Enhanced Monitoring Using Sensors After Surgery | Inpatients; Surgery | Recruiting | Not stated | 2026-02-10 | NCT06565559 | |
| Zimmer® Natural Nail® (ZNN) Bactiguard Tibia Post-Market Clinical Follow-up Study | Leg Injuries, bone fracture, injury, tibia fracture | Recruiting | Not stated | 2025-11-25 | NCT05022485 | |
| Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, idiopathic pulmonary fibrosis | Active, not recruiting | Phase 2 | 2024-08-23 | NCT05570058 | |
| The British Heart Foundation SENIOR-RITA Trial | Infarction, Necrosis, Non-ST Elevated Myocardial Infarction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute coronary syndrome, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2024-07-19 | NCT03052036 |